Showing 1-4 of 4 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Predicting Early Islet Graft Success: A Clinical-Omics Platform for Donor and Stem-Cell–Derived Therapies | INSERM | Francois Pattou | Cures | 01-August-2025 to 31-July-2027 | $748,640.92 |
| AUTOANTIGEN-SPECIFIC REGULATORY T CELL THERAPY AGAINST TYPE 1 DIABETES (ARTIDE) | INSERM | Simon Fillatreau | Cures | 04-September-2025 to 03-September-2028 | $334,011.00 |
| Benign beta-cell autoimmunity: mechanisms, biomarkers and therapeutic targeting by PD-1 agonist antibodies to prevent type 1 diabetes | INSERM | Sylvaine You | Cures | 01-April-2025 to 31-March-2028 | $330,880.00 |
| Prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes related complications: the SFDT1 study | APHP Hopital Lariboisiere | Jean-Pierre Riveline | Improving Lives | 01-July-2023 to 30-June-2026 | $900,000.00 |